Services search (in the department)
| Illness | Number of cases |
|---|---|
| Mental and behavioural disorders due to use of alcohol (F10.3) | 221 |
| Mental and behavioural disorders due to use of opioids (F11.3) | 75 |
| Mental and behavioural disorders due to use of cannabinoids (F12.3) | 72 |
| Mental and behavioural disorders due to use of cocaine (F14.3) | 68 |
| Mental and behavioural disorders due to use of sedatives or hypnotics (F13.3) | 37 |
| Mental and behavioural disorders due to use of other stimulants including caffeine (F15.3) | 28 |
| Mental and behavioural disorders due to use of alcohol (F10.4) | not specified |
| Mental and behavioural disorders due to use of opioids (F11.0) | not specified |
| Mental and behavioural disorders due to use of opioids (F11.4) | not specified |
| Mental and behavioural disorders due to use of cocaine (F14.2) | not specified |
| Treatment | Number |
|---|---|
| Detoxification treatment for addiction (8-985.1) | 336 |
| Detoxification treatment for addiction (8-985.0) | 144 |
| Computer-assisted analysis of the images with 3D-analysis (3-990) | 16 |
| (9-984.7) | 8 |
| Measurement of lung function in an airtight cabin - whole body plethysmography (1-710) | 7 |
| Computed tomography (CT) of the head without contrast medium (3-200) | 7 |
| Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711) | 6 |
| Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930) | 6 |
| Detoxification treatment for addiction (8-985.2) | 6 |
| (9-984.6) | 6 |
| Number | Group |
|---|---|
| 59 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 48 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 48 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
| Job | Explanation |
|---|---|
| Participation in multi-centre Phase I/II studies | |
| Lectureships / teaching posts at colleges and universities | Der Ärztliche Leiter Prof. Dr. med. Harald Matthes ist Inhaber des Stiftungslehrstuhls 'Integrative und Anthroposophische Medizin' an der Charité, Universitätsmedizin Berlin. PD Dr. med. Patricia Grabowski ist Privatdozentin an der Charité, Med. Klinik III, Hämatologie/Onkologie/Tumorimmunologie |
| Doctoral supervision | im Forschungsinstitut Havelhöhe www.fih-berlin.de |
| Participation in multi-centre phase III/IV studies | |
| Initiation and management of uni-centric/multi-centric clinical/scientific studies | |
| Student training (clinical traineeship / internship year) | PJ und Famulaturen in: Innere Medizin, Chirurgie und Plastische Chirurgie, Psychosomatik, Gynäkologie, Anästhesie, Radiologie |
| No. | Training in other healing professions | Comment |
|---|---|---|
| HB01 | Nurse and health care worker (m/f) | Es besteht eine enge Kooperation mit der Wannseeschule (Theorie). Der praktische Teil der Ausbildung findet im Gemeinschaftskrankenhaus Havelhöhe statt. Für die Auszubildenden gibt es eine zentrale Ausbildungskoordinatorin, in ihren praktischen Einsätzen werden sie durch Praxisanleitende begleitet. |
Dagmar Berger
Qualitätsmanagement und klinisches Risikomanagement
Phone:
030
-356501-6877
Mail:
ed.eheohlevah@regreb.ramgad
Dagmar Berger
Qualitätsmanagement und klinisches Risikomanagement
Phone:
030
-36501-6877
Mail:
ed.eheohlevah@regreb.ramgad
Prof. Dr. med. Harald Matthes
Ärztlicher Leiter
Phone:
030
-36501-7610
Mail:
ed.eheohlevah@sehttam.dlarah
Prof. Dr. med. Harald Matthes
Ärztlicher Leiter
Phone:
030
-36501-7610
Mail:
ed.eheohlevah@sehttam.dlarah